Geographically, North America dominated the biopsy needles market driven by world class healthcare infrastructure with a technologically advanced practice, higher spending and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for biopsy needles market. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.
This report identifies the biopsy needles market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the biopsy needles market.
This report segments the biopsy needles market on the basis of needle type, cancer type and regional market as follows:
Biopsy needles market research report is classified on the basis of needle type. Some of the major needle types covered in this report are as follows: Disposable Needle and Non Disposable Needle
Biopsy needles market research report is classified on the basis of cancer type. Some of the major cancer type covered in this report are as follows: Bone Marrow Cancer, Breast Cancer, Lung Cancer, Liver Cancer, Prostate Cancer and Others
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the biopsy needles market. Some of the major companies’ profiles in detail are as follows:
Medax Medical Devices
Argon Medical devices
Cardinal Health, Inc.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Biopsy needles Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Biopsy needles Market– Forces
4.1.1. Increasing prevalence of cancer
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Biopsy needles Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Biopsy needles Market, By Type
6.2. Non Disposable
7. Biopsy needles Market, By Cancer Type
7.1. Bone Marrow
8. Biopsy needles Market, By Geography
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.4. Rest of the World (RoW)
8.4.2. Rest of RoW
9. Biopsy needles Market – Entropy
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
10.1. Medax Medical Devices
10.2. Creganna Medica
10.4. Argon Medical devices
10.5. Cardinal Health, Inc.
10.6. Carefusion Corporation
10.7. C.R. Bard, Inc.
10.8. C.R. Bard, Inc.
10.9. DTR Medical
10.10. Hologic, Inc.
10.11. INRAD, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11.3. Research Methodology
11.5. Compilation of Expert Insights